ResearcherHospital Universitario de BurgosActive in the last 2 years

Ana María López Muñoz

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-5476-3957; OpenAlex author ID A5021745564. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 7

Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper

Papers 2

KRAS mutations in pancreatic cancer: could we talk about a risk factor for the development of thromboembolic phenomena? Last author DOI 10.17235/reed.2023.9926/2023 ↗
Phase II clinical trial of nab-paclitaxel plus gemcitabine in elderly patients with previously untreated locally advanced or metastatic pancreatic adenocarcino… Co-author DOI 10.1007/s00280-020-04214-w ↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Carmen Blanco Abad · 1 shared paper, 2024 · strength 0.23
- Paper KRAS mutations in pancreatic cancer: could we talk about a risk factor for the development of thromboembolic phenomena? DOI 10.17235/reed.2023.9926/2023 ↗
César Gutiérrez Pérez · 1 shared paper, 2024 · strength 0.23
- Paper KRAS mutations in pancreatic cancer: could we talk about a risk factor for the development of thromboembolic phenomena? DOI 10.17235/reed.2023.9926/2023 ↗
Mónica Jorge Fernández · 1 shared paper, 2021 · strength 0.11
- Paper Phase II clinical trial of nab-paclitaxel plus gemcitabine in elderly patients with previously untreated locally advanc… DOI 10.1007/s00280-020-04214-w ↗
Guillermo López-Vivanco · 1 shared paper, 2021 · strength 0.11
- Paper Phase II clinical trial of nab-paclitaxel plus gemcitabine in elderly patients with previously untreated locally advanc… DOI 10.1007/s00280-020-04214-w ↗
Ana Fernández Montés · 1 shared paper, 2021 · strength 0.11
- Paper Phase II clinical trial of nab-paclitaxel plus gemcitabine in elderly patients with previously untreated locally advanc… DOI 10.1007/s00280-020-04214-w ↗
Jaime Feliú · 1 shared paper, 2021 · strength 0.11
- Paper Phase II clinical trial of nab-paclitaxel plus gemcitabine in elderly patients with previously untreated locally advanc… DOI 10.1007/s00280-020-04214-w ↗
Teresa Mercade Macarulla · 1 shared paper, 2021 · strength 0.11
- Paper Phase II clinical trial of nab-paclitaxel plus gemcitabine in elderly patients with previously untreated locally advanc… DOI 10.1007/s00280-020-04214-w ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.